Palvella Therapeutics, Inc. (PVLA) vs Vir Biotechnology, Inc. (VIR)
- Palvella Therapeutics, Inc. PVLA 120.30 −5.53%
- Vir Biotechnology, Inc. VIR 9.96 −4.87%
Palvella Therapeutics, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. Palvella Therapeutics, Inc. and Vir Biotechnology, Inc. are of similar size ($1.8B and $1.8B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,495.9% against 146.7%. Palvella Therapeutics, Inc. has the higher net margin (0.00% vs −83.0%) and the higher return on invested capital (0.00% vs −39.1%). Across the 16 metrics below, Palvella Therapeutics, Inc. leads on 9 and Vir Biotechnology, Inc. on 7.
Valuation
Profitability
| Metric | PVLA | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (92.40%) | 0.00% |
| Net margin | 0.00% | (83.00%) | 0.00% |
| Free cash flow margin | 0.00% | (67.17%) | 0.00% |
| Return on equity | (46.63%) | (26.08%) | (56.36%) |
| Return on assets | (37.70%) | (20.91%) | (48.04%) |
| Return on invested capital | 0.00% | (39.10%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack